CGON
CG Oncology·NASDAQ
--
--(--)
--
--(--)
8.29 / 10
Outperform
Analyst sentiment is highly bullish: two analysts rate CGON Strong Buy, with one showing a 100% historical win rate. Fund‑flow scores 7.42/10, indicating solid inflows despite negative trend labels. Overall, capital and analyst views strongly support the stock.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate100.0%
What is the analyst consensus for CGON?
- CGON holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.29/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
